Comparisons between multigroups were determined by one-way ANOVA followed by a post-hoc t-test

stigate how the reduced Tm affects the efficiency of ASO:RNA duplex formation, a 37-nt ssRNA that contains the target site of siRNA 4676 was labeled with 33P and incubated with D4676, DM4676, LD4676 or LDM4676 at physiological temperature. ASO:RNA duplexes were detected immediately after the mixing of the ssRNA target and ASO. The 8-oxo-dG residues in all-DNA ASOs clearly reduced the efficiency of duplex formation. This effect was likely due to the reduced Tm of DM4676. The LNA/DNA gapmer ASO formed duplexes at least as efficiently as non-modified all-DNA ASO. Interestingly, 8-oxo-dG residues did not inhibit LNA/DNA gapmer ASO:RNA duplex formation, most likely because the Tm of the LDM4676:RNA duplex remained sufficiently high to ensure its effective formation. 8-oxo-dG residues have no adverse effects on RNase H-mediated cleavage of ASO:RNA duplexes LD4676 and LDM4676 formed duplexes with target RNA with similar efficiencies, and the duplexes formed by LD4676 were more stable. Nevertheless, in a cell-based 14 / 25 8-oxo-dG Modified LNA ASO Inhibit HCV Replication Fig 5. 8-oxo-dG residues reduce the Tm of duplexes between LNA/DNA gapmers and their targets. The effects of 8-oxo-dG residues on the Tm of LNA/DNA gapmer ASO:DNA and LNA/DNA gapmer ASO: RNA duplexes were measured by FRET. Target DNA or RNA oligonucleotides were labeled with TYE563 at the 3′-end; the D4676, LD4676 and LDM4676 probes had FAM at the 5′-end. The measurements were performed, and the data are presented as described for Fig 1. The effect of 8-oxo-dG residues on ASO:RNA duplex formation. Upper: schematic of the experimental setup. Applicable for some ASOs: Y, 8-oxo-dG MedChemExpress 606143-89-9 residue; +, LNA sugar base. Lower: the 33P-labeled 37-nt ssRNA target was mixed with the indicated ASOs. The samples were collected immediately or after incubation at 37C for the indicated times. The obtained probes were resolved by native PAGE in 15% gels and imaged using a Typhoon Trio instrument. The positions of the ASO:RNA duplexes and ssRNA are shown at right. Each panel represents data from one of three PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19696752 reproducible independent experiments. doi:10.1371/journal.pone.0128686.g005 assay, LDM4676 was a somewhat more efficient inhibitor of HCV replication. Therefore, we asked whether there were any differences in the ability of these duplexes to undergo RNase H-mediated target RNA cleavage. As human RNase H enzymes are not commercially available, we used bacterial RNase H, which has very similar fold and active center organization and shares many enzymatic properties with human RNase H enzymes. Pre-formed ASO:RNA duplexes, consisting of D4676, DM4676, LD4676, LDM4676 or an LNA/DNA mixomer oligonucleotide designated MixLD4676, and 33P-labeled 37-nt target RNA molecules were used to estimate the kinetics of RNase H-mediated cleavage. As expected, RNase H had no effect on ssRNA. Similarly, due to the absence of the obligatory 6-bp DNA:RNA duplex stretch required for RNase H activation, RNase H could not cleave the RNA strand in the MixLD4676:RNA duplex. In contrast, D4676:RNA and DM4676:RNA duplexes were rapidly cleaved. However, after 0.5 min, the reaction plateaued, leaving 2030% of the substrate uncleaved. PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19698359 The cleavage of 15 / 25 8-oxo-dG Modified LNA ASO Inhibit HCV Replication Fig 6. RNase H-mediated degradation of pre-formed ASO:RNA duplexes and in vitro-synthesized RNAs targeted by ASOs. Schematic of the experimental setup for panels B and C. Applicable for some ASOs: Y, 8-oxo-dG residue; +, LNA s